144 related articles for article (PubMed ID: 9876989)
1. Inhaled prostacyclin: from pulmonary hypertension to splanchnic hypoperfusion.
Brienza N
Intensive Care Med; 1998 Nov; 24(11):1228-30. PubMed ID: 9876989
[No Abstract] [Full Text] [Related]
2. Aerosolized prostacyclin and inhaled nitric oxide in septic shock--different effects on splanchnic oxygenation?
Eichelbrönner O; Reinelt H; Wiedeck H; Mezödy M; Rossaint R; Georgieff M; Radermacher P
Intensive Care Med; 1996 Sep; 22(9):880-7. PubMed ID: 8905421
[TBL] [Abstract][Full Text] [Related]
3. Epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
Botney M
N Engl J Med; 1998 Jun; 338(24):1773-4. PubMed ID: 9625639
[No Abstract] [Full Text] [Related]
4. Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery.
Lowson SM; Doctor A; Walsh BK; Doorley PA
Crit Care Med; 2002 Dec; 30(12):2762-4. PubMed ID: 12483070
[TBL] [Abstract][Full Text] [Related]
5. The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.
Gessler T; Seeger W; Schmehl T
Ther Adv Respir Dis; 2011 Jun; 5(3):195-206. PubMed ID: 21300738
[TBL] [Abstract][Full Text] [Related]
6. [Rebound effect after prostacyclin inhalation in pulmonary hypertension].
Moro JA; Almenar L; Morales P; Osa A
Med Clin (Barc); 2007 Jul; 129(7):279. PubMed ID: 17683713
[No Abstract] [Full Text] [Related]
7. Nebulized prostacyclin for pulmonary hypertension: a step in the right direction.
Wang A; Bashore TM
Eur Heart J; 1997 Sep; 18(9):1364-5. PubMed ID: 9458437
[No Abstract] [Full Text] [Related]
8. Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery.
Haché M; Denault A; Bélisle S; Robitaille D; Couture P; Sheridan P; Pellerin M; Babin D; Noël N; Guertin MC; Martineau R; Dupuis J
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):642-9. PubMed ID: 12658208
[TBL] [Abstract][Full Text] [Related]
9. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
Reddy MT; Patel H; Ventura HO
Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
[No Abstract] [Full Text] [Related]
10. Continuous intravenous prostacyclin for advanced primary pulmonary hypertension.
Archer-Chicko C
Dimens Crit Care Nurs; 2000; 19(2):14-21. PubMed ID: 10876492
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension--beyond vasodilator therapy.
Fishman AP
N Engl J Med; 1998 Jan; 338(5):321-2. PubMed ID: 9445414
[No Abstract] [Full Text] [Related]
12. Managing patients with primary pulmonary hypertension: prostacyclin therapy.
Albert NM; Hague K
Am J Crit Care; 1997 Jul; 6(4):274-80. PubMed ID: 9215424
[No Abstract] [Full Text] [Related]
13. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.
Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G
J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144
[TBL] [Abstract][Full Text] [Related]
14. Prostacyclin in the intensive care setting.
Ivy DD
Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S41-5. PubMed ID: 20216163
[TBL] [Abstract][Full Text] [Related]
15. Is there a place for prostacyclin in the treatment of septic shock?
De Backer D
Intensive Care Med; 2001 Jul; 27(7):1110-2. PubMed ID: 11534556
[No Abstract] [Full Text] [Related]
16. [Current status and future prospect of prostacyclin therapy for pulmonary hypertension--intravenous, subcutaneous, inhaled and oral PGI2 derivatives].
Saji T; Nakayama T; Ishikita T; Matsuura H
Nihon Rinsho; 2001 Jun; 59(6):1132-8. PubMed ID: 11411125
[TBL] [Abstract][Full Text] [Related]
17. Epoprostenol (prostacyclin) and pulmonary hypertension.
Fishman AP
Ann Intern Med; 2000 Mar; 132(6):500-2. PubMed ID: 10733452
[No Abstract] [Full Text] [Related]
18. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension.
Mikhail G; Gibbs J; Richardson M; Wright G; Khaghani A; Banner N; Yacoub M
Eur Heart J; 1997 Sep; 18(9):1499-504. PubMed ID: 9458458
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic evaluation of continuous intravenous epoprostenol.
Chaumais MC; Jobard M; Huertas A; Vignand-Courtin C; Humbert M; Sitbon O; Rieutord A; Montani D
Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1587-98. PubMed ID: 21077785
[TBL] [Abstract][Full Text] [Related]
20. The prostacyclin pathway in pulmonary arterial hypertension: a clinical review.
Del Pozo R; Hernandez Gonzalez I; Escribano-Subias P
Expert Rev Respir Med; 2017 Jun; 11(6):491-503. PubMed ID: 28399721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
